ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 976

Effect of Interactions Between Validated Rheumatoid Arthritis Genetic Factors and Environmental Factors On Rheumatoid Arthritis Risk

Chia-Yen Chen1, Linda T. Hiraki2, Susan Malspeis3, Jing Cui4, Bing Lu4, Robert M. Plenge5, Karen H. Costenbader4 and Elizabeth W. Karlson6, 1Department of Epidemiology, Harvard School of Public Health, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard School of Public Health, Boston, MA, 3Rheumatology, Brigham and Women's Hospital, Boston, MA, 4Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 5Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 6Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Environmental factors, genomics, human leukocyte antigens (HLA) and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Studies have shown associations between environmental factors and rheumatoid arthritis (RA) risk. Also, genome-wide association studies (GWAS) have identified genetic markers associated with RA risk. We examined additive and multiplicative gene-environment interactions between 44 RA genetic markers and smoking, parity/breast-feeding, body mass index (BMI), and BMI at age 18 in determining RA risk.

Methods:  We used a pooled nested case-control sample of 541 RA cases, including 303 seropositive (CCP+ and/or RF+) cases, and 549 matched controls from the Nurses’ Health Study and Nurses’ Health Study II. Controls were matched on age, menopausal status, and postmenopausal hormone use. All participants were Caucasian. We genotyped 36 single nucleotide polymorphisms identified in previous GWAS and meta-analysis, and 8 HLA-DBR1 shared epitope (SE) genotypes at 4 digit resolution. The information on cumulative pack-years of smoking, parity and months of breast-feeding prior and BMI variables determined prior to RA diagnosis, and BMI at age 18 was extracted from questionnaires. We examined the main effects of the genetic and environmental factors. We tested for additive interactions using the attributable proportion (AP) due to interaction and tested for multiplicative interactions using a 1 d.f. test. We used unconditional logistic regression models, adjusted for matching factors. Bonferroni correction was used to adjust for multiple comparisons. We further stratified the cases into seropositive RA and seronegative RA phenotypes and tested for interactions separately.

Results:  We found significant main effects of HLA-DBR1*0401 (OR=1.77, 95% CI=1.32-2.38), any HLA-DBR1 SE (OR=1.80, 95% CI=1.41-2.29), and smoking (OR=1.55, 95% CI=1.21-1.99) on RA risk. For the interaction analyses, combined HLA-DRB1 SE and HLA-DBR1*0401 showed significant interaction with smoking in all RA and seropositive RA. Also, PTPN22 showed significant interaction with smoking in all RA (Table). The effect of interaction between BMI prior to RA diagnosis and PXK on RA risk was significant in all RA (AP=0.74, p<0.005) and seropositive RA (AP=0.80, p<0.005). We also found significant interaction effects on RA risk between BMI at age 18 and HLA-DBR1*0401 in all RA (AP=0.66, p=0.013) and seropositive RA (AP=0.67, p=0.031). However, we did not find any significant interaction between genetic factors and parity/breast-feeding. Also, there was no significant interaction found in the seronegative RA phenotype. Several multiplicative interactions were significant, but none remained significant after multiple comparisons correction.

Conclusion:  We found significant gene-environment interaction effects on RA risk with stronger associations for the seropositive RA phenotype. We also found HLA-DBR1*0401 had different AP when interacting with different environmental factors, which suggests different mechanisms for these interactions.


Disclosure:

C. Y. Chen,
None;

L. T. Hiraki,
None;

S. Malspeis,
None;

J. Cui,
None;

B. Lu,
None;

R. M. Plenge,
None;

K. H. Costenbader,
None;

E. W. Karlson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-interactions-between-validated-rheumatoid-arthritis-genetic-factors-and-environmental-factors-on-rheumatoid-arthritis-risk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology